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Summary
Objective.— Analysis of changes in blood pressure with a two-year interval, and of factors
associated with this change, in a large cohort of elderly individuals.
Methods.— Follow-up of a cohort of 9294 individuals aged 65 years and over recruited from the
general population for Study 3C. Changes in blood pressure are deﬁned as the difference in its
averages between the inclusion visit and the follow-up visit at 2 years. The factors associated
with changes in systolic blood pressure were identiﬁed by univariate and multivariate analyses.
Results.— Systolic and diastolic blood pressure decreased on average by 7.60mmHg and
4.45mmHg respectively in 7659 individuals included in the study between the initial measure-
ment and the follow-up at 2 years. The analyses revealed that the initial high blood pressure
level was the main factor for this decrease that would be explained by a phenomenon of
regression towards the mean.
Conclusion.— These results conﬁrm the importance of repeating blood pressure measurements
during several examinations for a good estimate of individual blood pressure values in this
age range. It is also important to consider this phenomenon in studies including speciﬁc blood
pressure estimates only.
© 2009 Elsevier Masson SAS. All rights reserved.
∗ Corresponding author. Fax: +33 0 3 80 29 39 73.
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MOTS CLÉS
Pression artérielle ;
Sujet âgé ;
Cohorte ;
Hypertension
artérielle ;
Traitement
antihypertenseur ;
Régression vers la
moyenne
pression artérielle dans cette tranche d’âge. Il est également important de tenir compte de
ce phénomène dans les études ne comportant que des estimations ponctuelles de la pression
artérielle.
© 2009 Elsevier Masson SAS. Tous droits réservés.
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sntroduction
ascular diseases, and more speciﬁcally cerebrovascular
ccidents, in the elderly are a major cause of mortality and
andicap [1].
Hypertension is the most signiﬁcant modiﬁable risk factor
f these diseases [2]. Estimating its frequency, understand-
ng its determinants, its detection and management are
herefore part of the important public health challenges in a
ociety like ours in which life expectancy increases regularly.
The baroreﬂex alters with ageing, leading to a signiﬁ-
ant increase in blood pressure variability [3]. This increased
ariability can be reﬂected by a pressure increase when
easured by a professional (‘‘white coat hypertension’’
ffect) or a decrease sometimes masking hypertension.
geing also leads to increased arterial rigidity of the vas-
ular wall, which increases systolic blood pressure and
ecreases or stabilises diastolic blood pressure [4]. Never-
heless, the impact of these various phenomena on blood
ressure changes in time involving large samples of elderly
ndividuals is not widely known.
In this study, we analysed changes in blood pressure
etween the inclusion visit and the follow-up visit at 2 years
n a cohort of elderly individuals aged 65 years and over
ecruited from the general population, namely the Three-
ities Study (Study 3C) [5], and the factors associated with
hese changes.
articipants and methods
tudy populationhe participants of Study 3C were recruited between March
999 and March 2001 from three French cities, namely Bor-
eaux, Dijon and Montpellier. They were healthy volunteers,
ged 65 years and over, invited from electoral lists to partici-
t
s
o
d
aate in the study, and asked to return 2 years after inclusion.
veryone gave a written consent after the study protocol
as approved by the Ethics Committee of the Hôpital de
icêtre.
ollected data
he data collected initially and during the follow-up
ncluded the sociodemographic characteristics, the con-
umption of alcohol and tobacco, the main present and past
edical events, medical management and the use of medi-
ations.
Among the sociodemographic variables, our analysis con-
idered age (from 65 to 74 years, from 75 to 84 years
nd≥ 85 years), gender, the number of years within the
tudy (< 10 years and ≥ 10 years) and lifestyle.
The body mass index (BMI) was calculated from the
eight and height measured during examination (in kg/m2),
nd obesity was deﬁned by a BMI greater or equal to
0 kg/m2. Biochemistry parameters including serum choles-
erol and fasting blood glucose levels were determined:
iabetes was deﬁned by a blood glucose level greater
r equal to 7mmol/l (1.26 g/l) or the use of diabetic
reatment, and hypercholesterolaemia was deﬁned by a
holesterol level greater or equal to 7.25mmol/l (2.80 g/l)
r the use of lipid-lowering treatment.
The list of medications taken regularly during the previ-
us month was determined from the boxes of medications
nd prescriptions. These medications were coded according
o the French translation of the Anatomical Therapeutical
hemical (ATC) classiﬁcation of the World Health Organi-
ation (WHO). Concerning the consumption of alcohol andM. Lachouri et al.
Résumé
Objectif.— Analyse de l’évolution de la pression artérielle à deux ans d’intervalle, ainsi que
des facteurs associés à cette évolution, dans une grande cohorte de personnes âgées.
Méthodes.— Suivi d’une cohorte de 9294 personnes âgées de 65 ans et plus recrutées en popula-
tion générale pour l’étude 3C. L’évolution de la pression artérielle est déﬁnie par la différence
de ses moyennes entre la visite d’inclusion et celle de suivi à deux ans. Les facteurs asso-
ciés à l’évolution de la pression artérielle systolique ont été systématiquement recherchés par
analyses uni- et multivariées.
Résultats.— Chez les 7659 personnes incluses dans l’étude, la pression artérielle a diminué en
moyenne de 7,60mmHg pour la systolique et de 4,45 mmHg pour la diastolique entre l’examen
initial et le suivi à deux ans. Les analyses montrent que le niveau initial élevé de pression
artérielle est le facteur principal de cette diminution qui serait donc principalement expliquée
par un phénomène de régression vers la moyenne.
Conclusion.— Ces résultats conﬁrment l’importance de répéter les mesures de la pression
artérielle lors de plusieurs examens pour une bonne estimation des chiffres individuels deobacco, the participants were classiﬁed as current con-
umers on the one hand, and non- or former consumers
n the other. The history of vascular diseases (myocar-
ial infarction, chest angina, and cerebrovascular accidents)
nd the vascular risk factors (hypertension, hypercholes-
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analysis. At the follow-up visit of 2 years, 1264 participants
(including 25 deceased) had no measure of their blood pres-
sure and were also excluded. In total, the sample included
7659 participants (Fig. 1).Changes in blood pressure in a large cohort of elderly indivi
terolaemia and diabetes) were determined by asking the
patient.
The period since the last blood pressure measurement
was divided into two parts (less than one month and one
month or more) and the consultation frequency with a
general practitioner was divided into three parts (at least
every 2 months, 3 or 4 times a year and 0 to twice a
year).
Blood pressure: measurement and deﬁnition
of variables
During inclusion and follow-up, blood pressure was mea-
sured twice at each individual’s home after 5minutes in
a seating position using a standard cuff placed around the
right arm and an electronic monitor, the OMRON M4, val-
idated by the British Hypertension Society and the Agence
franc¸aise de sécurité sanitaire des produits de santé (French
health product safety agency). We used the average of both
blood pressure measurements in the analyses, noted as SPB
for systolic pressure and DPB for diastolic pressure. SBP
values were divided into four classes (< 140mmHg, 140 to
159mmHg, 160 to 179mmHg and ≥ 180mmHg). Pulse pres-
sure (PP) was deﬁned as the difference between the SBP and
the DBP.
A participant had to have at least one blood pressure
measurement at the initial visit and at the two-year follow-
up to be eligible for the study.
Individuals without a blood pressure measurement at the
initial visit, or at the two-year follow-up, and individuals
not seen at 2 years (deceased or lost to follow-up) were
excluded.
High blood pressure (HBP) was deﬁned as a SBP above or
equal to 140mmHg and/or a DBP above or equal to 90mmHg.
Persons were considered hypertensive, if the blood pressure
was high or if they were taking an antihypertensive treat-
ment, unless this was being given for a cardiac disease other
than hypertension as deﬁned in a previous article [6].
The HBP thresholds are those recommended by the WHO
for the management of hypertension in adults [7] but we also
performed analyses with higher thresholds (160/95mmHg)
still used for elderly individuals: as the general interpreta-
tion remained unchanged, we will only present the results
with the WHO deﬁnition of hypertension.
The variable of main relevance was the difference in
blood pressure measurements between the two-year visit
and the inclusion visit, noted as BP2—BP0, and calculated
for SBP, DBP and PP. An increase in blood pressure between
both visits therefore corresponded to a positive value in this
difference.
Since SBP is a better vascular risk predictor in the elderly
individual [8], we detailed changes in SBP and the associated
factors.
Analysis plan
The characteristics at inclusion were described, and then
compared with those of the non-included group so as to
identify any possible bias.
The averages of the initial and two-year blood pres-
sure measurements (SBP, DBP, PP), and of their differences
between inclusion and follow-up at 2 years, were studied.
F
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The change in SBP was analysed by considering sev-
ral factors, namely age, gender, years of study, lifestyle,
besity, diabetes, hypercholesterolaemia, consumption of
obacco and alcohol, history of cardiovascular diseases,
eriod since the last blood pressure measurement, fre-
uency of consultations with general practitioner, blood
ressure at inclusion and antihypertensive treatment at the
nitial visit or at the follow-up visit at 2 years [7—10].
In order to better understand the respective roles of the
lood pressure level and the antihypertensive treatment (at
nclusion and 2 years later), we performed a strata analysis
ith crossover of these variables.
We simultaneously analysed the roles of the different
ariables on the changes in SBP using step-by-step multiple
inear regression arranged in ascending order: the explica-
ive variables were those with a clinical meaning, namely
ge, gender, lifestyle, diabetes and history of cardiovascu-
ar diseases, antihypertensive treatment and SBP level at
nclusion.
Changes in PP within the 2 years following inclusion
ere also studied but since the general interpretation was
nchanged, we only present the results with SBP.
A p < 0.05 value was considered signiﬁcant. The statistical
nalysis was performed using the SAS version 9.1 software
SAS Institute, Cary, NC, United States).
esults
haracteristics of the sample
ut of 9294 participants in the 3C Study, 371 with no blood
ressure measured at the initial visit were excluded from theigure 1. Participants in study on the changes in blood pressure
etween the inclusion visit and the follow-up visit at 2 years.
1 M. Lachouri et al.
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Table 1 Characteristics of sample.
N = 7659
Sociodemographic factors
Average age (standard deviation) (Years) 74.0 (5.4)
Age group (%)
65—74 57.2
75—84 38.1
≥ 85 4.7
Men (%) 39.0
Years of study≥ 10 years (%) 39.5
Lifestyle (%)
Alone 36.1
In relationship 60.2
Other 3.7
Medical history and cardiovascular risk factors
Obesitya (%) 12.7
Diabetesb (%) 9.6
Hypercholesterolaemiac (%) 37.7
Current smokers (%) 5.3
Current drinkers (%) 80.6
Cardiovascular diseasesd (%) 9.2
Medical management
Last blood pressure measurement under
1 month ago (%)
61.4
Frequency of consultation with general
practitioner (%)
At least twice monthly 36.2
3 to 4 times a year 39.6
0 to twice a year 24.2
Antihypertensive treatment (%) 48.8
Blood pressure average upon inclusion
(standard deviation) (mmHg)
SBP 146.5 (21.7)
DBP 82.3 (11.3)
PP 64.5 (16.8)
Hypertensione upon inclusion (%)
77.1
a Body mass index≥ 30 kg/m2.
b Blood glucose≥ 7 mmol/l (1.26 g/l) or diabetes treatment.
c Cholesterol level≥ 7.25 mmol/l (2.80 g/l) or lipid-lowering30
The characteristics of the sample at inclusion are
etailed in Table 1: the average age was 74 years, 61% of par-
icipants were women, 13% were obese, 10% were diabetic
nd 9% had a history of cardiovascular diseases.
The average blood pressure was 146.5/82.3mmHg and
he average PP was 64.5mmHg. Close to half of partic-
pants received an antihypertensive treatment and over
hree quarters had hypertension according to the convention
ndicated earlier.
The comparisons of the sample with the non-included
ndividuals revealed that the latter were older (76.1 [stan-
ard deviation = 6.1] vs 74.2 [5.4] years, p < 0.0001) and had
higher vascular risk: more diabetes (15% vs 10%), more
ypertension (81% vs 77%) and greater history of cardiovas-
ular diseases (13% vs 9%).
ariations in blood pressures
etween the two-year visit and the initial visit, we observed
decrease of 7.60mmHg in SBP and 4.45mmHg in DBP
Table 2). The corresponding PP drop was 3.15mmHg. This
BP drop was observed in all strata deﬁned in the analysis
lan (Table 3 ): it appeared to increase with age and the
resence of obesity. The factor associated with the greatest
BP variability was the initial blood pressure rate; thus, the
BP increased by 1.17mmHg in those with an initial SBP rate
elow 140mmHg, and decreased in all other strata, down
y 30mmHg in those with an initial SBP above 180mmHg
Table 3).
The use of an antihypertensive treatment (upon inclu-
ion in the study or 2 years later) was also associated with
decrease in SBP during follow-up. To continue exploring
hese results, we studied the SBP variation by looking at the
ombinations of blood pressure rate upon inclusion with the
se of an antihypertensive treatment.
mpact of the initial blood pressure rate and
ntihypertensive treatment on the changes in
lood pressure
n normotensive participants upon inclusion in the study
SBP≤ 140mmHg and DBP≤ 90mmHg) and not taking any
reatment, the SBP was practically unchanged during follow-
p in those still not taking an antihypertensive treatment
SBP2—SBP0 = 0.08mmHg, Table 4). However, when a treat-
ent was initiated, we observed an average SBP decrease
f approximately 4.3mmHg. In normotensive participants
Table 2 Blood pressure averages and their differences between follow-up at 2 years (BP2) and inclusion (BP0).
BP0 BP2 BP2 — BP0
SBP (SD) in mmHg; [range] 146.5 (21.7) 138.9 (21.0) —7.60 (19.80)
[85.5; 261.0] [71.0; 240.5] [—98.00; 79.50]
DBP (SD) in mmHg; [range] 82.3 (11.3) 77.9 (11.1) —4.45 (11.16)
[50.5; 154.0] [42.5; 159.5] [—70.00; 89.50]
PP (SD) in mmHg; [range] 64.5 (16.8) 61.1 (16.1) —3.15 (15.26)
[15.0; 138.5] [17.0; 147.5] [—93.50; 66.00]
Average in mmHg (standard deviation) [range]. SBP: Systolic blood pressure; DBP: Diastolic blood pressure; PP: Pulse pressure.
treatment.
d Surgery of leg arteries if arteritis, cerebrovascular accident,
myocardial infarction and heart surgery.
e Systolic blood pressure≥ 140mmHg and diastolic blood pres-
sure≥ 90mmHg or antihypertensive treatment.
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Table 3 Factors associated with the difference in sys-
tolic blood pressure between the follow-up at 2 years
(SBP2) and inclusion (SBP0).
SBP2—SBP0
Age group (years)
65-74 —7.28 (18.62)
75-84 —7.86 (21.11)
≥ 85 —9.40 (23.28)
Gender
Woman —7.77 (19.85)
Man —7.49 (19.84)
Years of study
< 10 years —7.60 (20.25)
≥ 10 years —7.59 (19.23)
Lifestyle
Alone —7.10 (20.20)
In relationship —7.92 (19.54)
Obesitya
No —7.42 (19.61)
Yes —8.89 (21.09)
Diabetesb
No —7.62 (19.65)
Yes —7.12 (21.55)
Hypercholesterolaemiac
No —7.35 (19.51)
Yes —7.91 (20.36)
Consumption of tobacco
Current smokers —7.68 (19.93)
Non- or former smokers —6.13 (18.31)
Consumption of alcohol
Current drinkers —7.44 (19.75)
Non- or former drinkers —8.25 (20.21)
Cardiovascular diseasesd
No —7.50 (19.61)
Yes —8.55 (22.05)
Period since last blood pressure
measurement
< 1month —7.28 (20.20)
≥ 1month —8.11 (19.22)
Frequency of consultation with
general practitioner
At least once or twice/month —7.02 (21.22)
3 to 4 times/year —8.44 (19.54)
Never or less than twice/year —7.09 (18.11)
Systolic blood pressure upon inclusion
< 140mmHg 1.17 (16.83)
140—159mmHg —7.91 (17.15)
160—179mmHg —17.30 (18.62)
≥ 180mmHg —30.04 (21.30)
Antihypertensive treatment upon
inclusion
No —6.88 (18.01)
Yes —8.36 (21.58)
Table 3 (Continued )
SBP2—SBP0
Antihypertensive treatment at 2 years
No —5.11 (17.21)
Yes —9.69 (21.59)
Average in mmHg (standard deviation).
a Body mass index≥ 30 kg/m2.
b Blood glucose≥ 7mmol/l (1.26 g/l) or diabetes treatment.
c Cholesterol level≥ 7.25mmol/l (2.80 g/l) or lipid-lowering
treatment.
d Surgery of the leg arteries if arteritis, cerebrovascular acci-
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n antihypertensive treatment — controlled hypertensives—
he SBP increased by approximately 3.5mmHg 2 years
ater, and as expected, this increase was higher in
hose who had discontinued an antihypertensive treatment
SBP2—SBP0 = 7.2mmHg) than in those still taking the treat-
ent (SBP2 — SBP0 = 3.2mmHg).
Among the individuals with an initial HBP, the SBP
ecreased at 2 years in both those who had an antihyperten-
ive treatment upon admission to the study (−12.2mmHg)
nd those without treatment (−13.6mmHg). In both these
roups, the decrease was more signiﬁcant with an antihyper-
ensive treatment at 2 years. Finally, we should emphasize
hat the blood pressure drop in this group with a HBP
pon inclusion was regardless of the use of an antihyper-
ensive treatment during follow-up, and this is witnessed
n those without antihypertensive treatment upon inclu-
ion (−10.5) as much as in those with treatment (−7.5)
Table 4).
actors associated with a SBP variation in
ultivariate analysis
able 5 presents the multiple linear regression results
pplied to changes in SBP after adjusting for the cen-
er. The Student’s t test result is provided for each
oefﬁcient.
The variables associated with a SBP increase during
ollow-up are age, diabetes, antihypertensive treatment
pon inclusion and gender. However, initial increased
BP, history of cardiovascular diseases and relation-
hip lifestyle were associated with a drop in blood
ressure.
iscussion
tudy 3C was conducted among the general population in
ndividuals aged 65 years and over, volunteers who were
ot in-patients, and perhaps more concerned with their
ealth and in a better general condition than the entire
opulation of elderly individuals as they experienced good
edical management (frequent consultation with a general
ractitioner, regular measurement of blood pressure, anti-
ypertensive treatment).
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Table 4 Difference in blood pressure between follow-up at 2 years (SBP2) and inclusion (SBP0) according to the pressure
rate at inclusion and antihypertensive treatment at inclusion and at 2 years.
Upon inclusion Follow-up at 2 years
Total Without treatment With treatment
SBP < 140mmHg and DBP < 90mmHg
Without treatment numbers (%) 1753 (22.9) 1594 (20.8) 159 (2.1)
SBP0 124.9 (10.5) 124.8 (10.6) 125.9 (9.6)
SBP2 124.6 (16.5) 124.9 (16.5) 121.6 (16.4)
SBP2—SBP0 —0.31 (15.36) 0.08 (15.21) —4.29 (16.27)
With treatment numbers (%) 1149 (15.0) 93 (1.2) 1056 (13.8)
SBP0 127.1 (9.9) 123.1 (11.0) 127.4 (9.7)
SBP2 130.6 (18.0) 130.3 (18.8) 130.6 (18.0)
SBP2—SBP0 3.52 (18.54) 7.18 (18.68) 3.19 (18.51)
SBP≥ 140mmHg or DBP≥ 90mmHg
Without treatment numbers (%) 2169 (28.3) 1714 (22.4) 455 (5.9)
SBP0 157.1 (15.6) 155.3 (14.1) 163.9 (18.8)
SBP2 144.9 (18.7) 144.9 (17.9) 145.2 (21.8)
SBP2—SBP0 —12.19 (18.26) —10.47 (16.92) —18.66 (21.41)
With treatment numbers (%) 2588 (33.8) 95 (1.2) 2493 (32.6)
SBP0 161.0 (16.7) 158.2 (16.2) 161.1 (16.7)
SBP2 147.4 (20.4) 150.7 (21.9) 147.2 (20.3)
SBP2—SBP0 —13.63 (20.72) —7.47 (19.97) —13,86 (20.72)
re; DBP: Diastolic blood pressure.
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ciated with a SBP increase, while gender, history of
cardiovascular diseases, hypertension treatment at 2 years
and initial blood pressure were signiﬁcantly associated with
a SBP decrease.
Table 5 Multivariate analysis of factors associated with
changes in systolic blood pressure between inclusion and
follow-up at 2 years.
Variables Multiple regression
coefﬁcients
p*
Constant —9.74 0.001
Age 0.11 0.004
Man 3.61 < 0.0001
Diabetesa 2.27 0.001
Relationship lifestyle —1.67 0.0003
Cardiovascular
diseasesb
—2.12 < 0.001
Antihypertensive
treatment upon
inclusion
1.25 0.003
Systolic blood pressure
upon inclusion
< 140mmHg
140—159mmHg —9.47 < 0.0001
160—179mmHg —18.78 < 0.0001
≥ 180mmHg —31.61 < 0.0001Average in mmHg (standard deviation); SBP: Systolic blood pressu
easurement of blood pressure upon inclusion
nd at 2 years
here was little difference between the two blood pressure
easurements at inclusion and the two-year follow-up visit,
nd the average of these two measurements was calculated
utomatically so as to have a low variance of accuracy.
epresentativeness of the sample
he individuals included in our study presented with an
verage blood pressure at inclusion of 146.54/82.30mmHg,
hich was higher than that (122.9/72.1mmHg) measured in
n American study involving adults from the general popula-
ion [9], but only 2.65% of patients studied had grade 3 blood
ressure (SBP ≥ 180 and DBP≥ 110mmHg). However, the
revalence of hypertension in these individuals (77.11%) was
omparable to that (76%) seen in a survey conducted among
rench general practitioners [11] involving a population of
he same age.
The 3C individuals ‘‘not included’’ in our study had no
igher blood pressures than those included, despite having
greater cardiovascular risk (advanced age, diabetes, smok-
ng, cardiovascular diseases —myocardial infarction, heart
urgery (bypass), coronary angioplasty (dilation), surgery
o leg arteries if arteritis, cerebrovascular accident— and
ypertension).actors associated with variation in blood
ressure observed 2 years after inclusion
he multifactorial study revealed that age, diabetes and
ypertension treatment at inclusion were signiﬁcantly asso-
* p: probability adjusted for the center.
a Blood glucose≥ 7mmol/l or diabetes treatment.
b Surgery of the leg arteries if arteritis, cerebrovascular acci-
dent, myocardial infarction and heart surgery.
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Age
SBP increases signiﬁcantly with age, which has already been
observed [12], and results from age correlations with anti-
hypertensive treatment (at inclusion and at 2 years), history
of cardiovascular disease and obesity.
Diabetes and cardiovascular history
SBP increases with diabetes but decreases with history of
cardiovascular diseases, consistent with an American study
in which diabetic patients were not signiﬁcantly better con-
trolled and patients with a history were better controlled
[6,9].
Gender
SBP decreases more dramatically in women than men, as
opposed to the result [13] that found no signiﬁcant differ-
ence in control with gender, but according to an observation
on blood pressure measurements at inclusion only [6] when
women were better controlled than men.
Possible causes of variation in blood pressure
Overall, blood pressure was lower after 2 years in included
individuals, without any signiﬁcant variation in the heart
rate (HR in bpm=70.0 [10.7] at inclusion vs 69.9 [11.1] after
2 years).
In normotensive individuals (treated or not at inclusion
and treated or not 2 years later), the average SBP was stable
from inclusion to 2 years: its variation was at most 7mmHg,
a value that corresponds with a seemingly normal increase
in a patient treated at inclusion but not at 2 years.
In hypertensive individuals treated at 2 years, and
treated or not at inclusion, SBP decreased, which may result
from an antihypertensive treatment since the most signif-
icant decrease was observed in the cases not treated at
inclusion.
In hypertensive individuals not treated at 2 years but
treated at inclusion, SBP decreased, which may be explained
by diet and physical activity.
Finally, in hypertensive individuals treated neither at
2 years or inclusion, SBP also decreased a little (average
variation of 10mmHg), which may be partly explained by
an overestimation of blood pressure at the inclusion visit.
We therefore observed that SBP decreased in hyperten-
sive individuals, all the more so when the initial blood
pressure was higher.
A ﬁrst explanation is a variation in the measurement
method. Nevertheless, all BP measurements were per-
formed at home by investigators using an automatic BP
measuring device. They ﬁrst trained on several occasions
on the BP measuring method with this type of device by
using a booklet summarising the main points. As the study
progressed, we also compared the BP values measured by
the different investigators without noting any signiﬁcant
difference between the average BP values taken by each
investigator. It is therefore unlikely that the changes in BP
ﬁgures may be related to a measurement error.
A second explanation for the SBP decrease could be
offered by the hypertensive individuals with no initial treat-
ment and the intervention of a practising physician. The
practising physician having found an increase SBP may have
t
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laced the patient on treatment. Treatment compliance was
mportant with our participants because elderly individuals
enerally tend to be more persistent with their treatment
nd to tolerate its side effects [14].
If the patient was already receiving a treatment, the
ractising physician may have also encouraged the regular
se of a current treatment, enabling to improve compliance.
owever, this is not a major explanation as the most signiﬁ-
ant blood pressure decrease was observed in patients with
o initial treatment or two-year treatment.
A third explanation is that SBP was overestimated at the
nclusion visit by the ‘‘white coat hypertension’’ effect:
lood pressure in the elderly increases due to the apprehen-
ion created by the visit of an unknown person and inclusion
n a study, and this effect would be weakened at 2 years
ecause the elderly individual would ﬁnd themselves in a
amiliar situation.
A fourth explanation, valid for all hypertensive indi-
iduals, is that the health and diet practices usually
ecommended by the French national health authority (HAS)
15] (decrease consumption of salt and meat, increase phys-
cal exercise), which were not encouraged by the Study
C, may have been recommended by general practition-
rs. These practises are actually not always beneﬁcial to
lderly individuals, who sometimes prefer to restrict them-
elves to health and dietary advices. Nevertheless, we did
ot observe any behavioural change in diet or physical activ-
ty in this cohort. In addition, these practices could have
ed to a weight loss, which was not observed in the patients
tudied (weight in kg 67.4 [12.8] at inclusion and 67.5 [13.1]
fter 2 years).
One last explanation is provided by the phenomenon
f regression towards the mean [16], very well-known in
he ﬁeld of hypertension: this effect, which appears when
xtreme values (very high or very low) are numerous at the
rst measurement, and which is purely statistical because
elated to the intra-individual variability [15], enables to
nderstand that the very high (or very low) values will be
loser to the mean value by decreasing (or by increasing).
his explanation completes the previous ones, particularly
ecause the regression towards the mean may have followed
he ‘‘white coat hypertension’’ effect.
Since blood pressure variability is more intense in elderly
ndividuals [17], the age of people monitored in the cohort
ay have contributed to the increase in this phenomenon:
he emphasis of BP decrease with age observed in this
tudy is suggestive of this hypothesis. We could then
ssume that the BP measurement in elderly individuals,
ue to a more signiﬁcant apprehension during the inclu-
ion visit, was overestimated. The BP drop during follow-up
ould then be a return to the usual values for these
articipants.
These results conﬁrm the importance of measuring
P at different times before establishing a diagnosis of
ypertension in an elderly individual. They also call for care-
ul observation of the results from studies in which this
epeated measurement is impossible to perform for prac-
ical reasons, speciﬁcally studies involving large groups of
ndividuals like epidemiological studies or therapeutic tri-
ls. Ignoring this phenomenon would lead to overestimating
he frequency of hypertension or the efﬁcacy of therapeutic
easures in elderly individuals.
1C
T
7
v
f
s
m
t
w
i
f
e
i
a
i
u
v
r
m
s
r
R
[
[
[
[
[
[
[34
onclusion
his study revealed a strong blood pressure variability in
659 participants aged 65 years and over from the inclusion
isit to the follow-up visit at 2 years: mainly, treatment
or hypertension during inclusion was associated with a
mall increase in blood pressure (when there was no treat-
ent at 2 years) while ongoing treatment noted at the
wo-year follow-up was associated with a notable decrease,
hich justiﬁed hypertension treatment of the elderly
ndividual.
These results are explained by a combination of dif-
erent phenomena (mainly the ‘‘white coat hypertension’’
ffect and the regression towards the mean) and it is
mpossible to differentiate these phenomena with the data
vailable.
While descriptive, this study highlights the clinical signif-
cance of reliable blood pressure measurement: the results
nderline the need to multiply measurements in elderly indi-
iduals because every isolated blood pressure measurement
isks being biased. It is therefore essential to repeat the
easurement at relatively short time intervals (two visits
paced out by a few days) to establish blood pressure accu-
ately.
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